title: The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.
abstract: Argatroban is a synthetic direct thrombin inhibitor with a relative short elimination half-life of 45 minutes and elimination which is predominantly performed via hepatic metabolism. Argatroban anticoagulation has been systematically studied in patients exhibiting the heparin-induced thrombocytopenia (HIT)/thrombosis syndrome and demonstrated to be a safe and effective therapy in this indication. Moreover, in smaller studies argatroban has also been assessed in special clinical settings in non-HIT patients. The current review presents the pharmacology of argatroban, data regarding monitoring of the agent, and an overview of the results of the major clinical trials assessing argatroban anticoagulation in HIT patients. Additionally, data from clinical trials with argatroban use outside HIT, in more special indications such as in percutaneous coronary intervention, stroke, renal replacement therapy, and intensive care medicine, are reviewed.
authors.affiliation: Department of Anesthesia, Deutsches Herzzentrum Berlin, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Koster
authors.forename: Karl-Georg
authors.initials: KG
authors.lastname: Fischer
authors.forename: Sebastian
authors.initials: S
authors.lastname: Harder
authors.forename: Fritz
authors.initials: F
authors.lastname: Mertzlufft
references.citation: N Engl J Med. 2005 Sep 8;353(10):1028-40
references.pmid: 16148288
references.citation: Ann Pharmacother. 2003 May;37(5):652-4
references.pmid: 12708939
references.citation: J Thromb Thrombolysis. 2004 Aug;18(1):31-7
references.pmid: 15744551
references.citation: Ann Pharmacother. 2003 Sep;37(9):1237-40
references.pmid: 12921506
references.citation: Circulation. 1999 Aug 10;100(6):587-93
references.pmid: 10441094
references.citation: Catheter Cardiovasc Interv. 2002 Oct;57(2):177-84
references.pmid: 12357516
references.citation: Am Heart J. 2006 Jun;151(6):1131-8
references.pmid: 16781211
references.citation: N Engl J Med. 2006 Nov 23;355(21):2203-16
references.pmid: 17124018
references.citation: Pharmacotherapy. 2000 Mar;20(3):318-29
references.pmid: 10730687
references.citation: Clin Appl Thromb Hemost. 2005 Jul;11(3):279-87
references.pmid: 16015413
references.citation: Arch Neurol. 2006 Aug;63(8):1057-62
references.pmid: 16908730
references.citation: Eur J Haematol. 2007 Feb;78(2):161-6
references.pmid: 17328717
references.citation: Blood Coagul Fibrinolysis. 2005 Jun;16(4):251-7
references.pmid: 15870544
references.citation: J Invasive Cardiol. 2003 Nov;15(11):611-6
references.pmid: 14608128
references.citation: JAMA. 2003 Feb 19;289(7):853-63
references.pmid: 12588269
references.citation: J Thromb Thrombolysis. 2005 Jun;19(3):183-8
references.pmid: 16082605
references.citation: Thromb Haemost. 1994 Sep;72(3):381-6
references.pmid: 7855788
references.citation: Am J Health Syst Pharm. 2002 Nov 1;59(21):2078-83
references.pmid: 12434720
references.citation: J Thromb Thrombolysis. 2006 Dec;22(3):169-76
references.pmid: 17103051
references.citation: J Thorac Cardiovasc Surg. 2006 Sep;132(3):699-700
references.pmid: 16935137
references.citation: Thromb Haemost. 2005 Nov;94(5):958-64
references.pmid: 16363236
references.citation: Pharmacotherapy. 2004 Mar;24(3):409-14
references.pmid: 15040656
references.citation: Circulation. 2004 Nov 2;110(18):e454-8
references.pmid: 15520327
references.citation: Thromb Haemost. 2004 Jun;91(6):1137-45
references.pmid: 15175800
references.citation: Circulation. 1999 Jan 5-12;99(1):73-80
references.pmid: 9884382
references.citation: Semin Thromb Hemost. 2004 Jun;30(3):273-83
references.pmid: 15282649
references.citation: Nephrol Dial Transplant. 1995 Nov;10(11):2137-40
references.pmid: 8643186
references.citation: Kidney Int. 2004 Dec;66(6):2446-53
references.pmid: 15569338
references.citation: Stroke. 2004 Jul;35(7):1677-82
references.pmid: 15155959
references.citation: Ann Pharmacother. 2007 May;41(5):749-54
references.pmid: 17440009
references.citation: Am J Health Syst Pharm. 2002 Jul 1;59(13):1258-66
references.pmid: 12116891
references.citation: Ann Pharmacother. 2005 Oct;39(10):1601-5
references.pmid: 16131539
references.citation: Ann Pharmacother. 2004 Jan;38(1):25-9
references.pmid: 14742788
references.citation: J Clin Pharmacol. 1999 May;39(5):513-9
references.pmid: 10234600
references.citation: Ann Pharmacother. 2005 Feb;39(2):231-6
references.pmid: 15632219
references.citation: Chest. 2006 May;129(5):1167-75
references.pmid: 16685006
references.citation: Arch Intern Med. 2003 Aug 11-25;163(15):1849-56
references.pmid: 12912723
references.citation: Circulation. 2001 Apr 10;103(14):1838-43
references.pmid: 11294800
references.citation: Lancet. 2002 Jan 26;359(9303):294-302
references.pmid: 11830196
references.citation: J Am Coll Cardiol. 1999 Jun;33(7):1879-85
references.pmid: 10362188
references.citation: Chest. 2005 Feb;127(2 Suppl):27S-34S
references.pmid: 15706028